N.K. Terrett - Concepedia

Author

N.K. Terrett

Also Known As

N TERRETT, N Terrett, N. K. TERRETT, N. K. Terrett, N.K Terrett, N.K. Terrett, Nicholas K Terrett, Nicholas K. Terrett, Nicholas Kenneth Terrett, Nick Terrett

223

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)University of Nottingham Pfizer (United States)Shanghai Institute of Materia Medica Chinese Academy of Sciences

About

N.K. Terrett is an author at Pfizer (United Kingdom) specializing in organic chemistry, chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.1K
2	Natural Sciences	9	9	377
3	Engineering	7	7	371
4	Biomolecular Engineering	7	7	885
5	Biochemistry	6	6	273

N.K. Terrett

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Combinatorial synthesis — the design of compound libraries and their application to drug discovery N.K. Terrett, Mark Gardner, David W. Gordon, Tetrahedron Combinatorial ChemistryDrug DesignMedicineRational Drug DesignCombinatorial Synthesis	1995	657
Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction N.K. Terrett, Andrew Bell, David Brown, Bioorganic & Medicinal Chemistry Letters Erectile DysfunctionSexual DysfunctionType 5PharmacologyMale Erectile Dysfunction	1996	602
Comparison of algorithms for dissimilarity-based compound selection M. Snarey, N.K. Terrett, Peter Willett, Journal of Molecular Graphics and Modelling EngineeringData MiningPattern RecognitionDissimilarity-based Compound SelectionFeature Selection	1997	200
Stereospecific syntheses and reactions of allyl- and allenyl-silanes Ian Fleming, N.K. Terrett Journal of Organometallic Chemistry Organic ChemistryStereoselective SynthesisChemistryAsymmetric CatalysisStereospecific Syntheses	1984	123
The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity Benjamin A. Seigal, William H. Connors, Andrew W. Fraley, Journal of Medicinal Chemistry Lead CompoundsMolecular BiologyLead IdentificationChemical BiologyPharmaceutical Chemistry	2015	85
UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic John C. Danilewicz, Paul L. Barclay, I. T. Barnish, Biochemical and Biophysical Research Communications Molecular PharmacologyNovel InhibitorMedicinePhysiologyEc 3.4.24.11	1989	68
Parallel-compound synthesis: Methodology for accelerating drug discovery Christopher N. Selway, N.K. Terrett Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryNatural SciencesDrug DesignMedicine	1996	65
Radical cyclisations of imines and hydrazones W. Russell Bowman, Peter T. Stephenson, N.K. Terrett, Tetrahedron HeterocyclicRadical (Chemistry)Organic ChemistryChemistryRadical Cyclisations	1995	61
Methods for the synthesis of macrocycle libraries for drug discovery N.K. Terrett Drug Discovery Today Technologies Combinatorial ChemistryTargeted LibraryBiochemistryNatural SciencesMedicine	2010	59
Radical cyclisations of dienes and enynes using phosphorus- and sulfur-centred radicals Julie E. Brumwell, Nigel S. Simpkins, N.K. Terrett Tetrahedron Sulfur-centred RadicalsEngineeringHeterocyclicRadical (Chemistry)Organic Chemistry	1994	50

Page 1